From Our Thought Leaders

Andelyn and PQP Group Partner to Simplify Cell and Gene Therapy Supply Across Europe

Expanding cell and gene therapy trials into Europe presents challenges in regulatory compliance, import procedures, product handling and clinical supply. Andelyn and PQP Group have partnered to coordinate manufacturing, Qualified Person certification... Read more

19 November, 2026 | Thursday | Interaction
AAVantgarde Advances Dual-AAV Gene Therapies for Usher Syndrome and Stargardt Disease

Inherited retinal diseases such as Usher syndrome and Stargardt disease remain difficult to treat, particularly when the genes involved are too large for conventional gene therapy delivery systems. AAVantgarde is advancing its dual-AAV platform throu... Read more

17 November, 2026 | Tuesday | Interaction
Quotient Sciences Advances AI-Guided Drug Formulation to Shorten Clinical Development

Developing effective drug formulations remains a major challenge for biopharma companies, particularly for molecules with poor solubility or complex release requirements. Quotient Sciences is exploring how machine learning and integrated manufacturin... Read more

16 November, 2026 | Monday | Interaction
MRM Health and Biocodex Advance €15 Million Manufacturing Partnership for Microbiome-Based Medicines

Bringing microbiome-based therapies to patients requires more than promising clinical results. Manufacturing complex mixtures of live bacteria consistently and at commercial scale remains a major challenge. MRM Health is addressing this through its p... Read more

13 November, 2026 | Friday | Interaction

Bio Finance

Bavarian Nordic Launches Second DKK 250 Million Share Buyback Tranche Under DKK 750 Million Programme

Bavarian Nordic A/S (OMX: BAVA) launches the second tranche of the share buy-back program announced on August 21, under which the Company intends to repurchase own shares for up to DKK 750 million. The second tranche will comprise buy-back of shares ... Read more

16 November, 2026 | Monday | News
ArrayPatch Raises €3.2 Million in Seed Funding to Advance Microneedle Patch Treatments for Obesity and Cancer

ArrayPatch Ltd (“ArrayPatch”), a biotech company developing innovative microneedle-based therapeutics, announced the successful completion of the second close of its seed financing round, securing an additional €1.6 million, bringing... Read more

06 November, 2026 | Friday | News

Contract Services

Labcorp Partners with Grupo Fleury to Expand Clinical Trial Laboratory Operations in Brazil

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced a collaboration with Grupo Fleury, one of Brazil's leading healthcare and diagnostic groups, with extensive laboratory infrastructure, scientific ... Read more

19 November, 2026 | Thursday | News
Erasca and Bristol Myers Squibb Partner to Test ERAS-0015 Combination in Pancreatic Cancer

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, announced a clinical trial collaboration and supp... Read more

19 November, 2026 | Thursday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close